(Q46511484)

22 December 2017

title

The four-plates test-retest paradigm to discriminate anxiolytic effects (English)

1 reference

22 December 2017

4

Michel Bourin

1 reference

22 December 2017

Martine Hascoët

5

object named as

Martine Hascoët

1 reference

22 December 2017

Nadège Ripoll

1

object named as

Nadège Ripoll

1 reference

22 December 2017

Bríd Aine Nic Dhonnchadha

2

object named as

Bríd Aine Nic Dhonnchadha

1 reference

22 December 2017

author name string

Véronique Sébille

3

1 reference

22 December 2017

publication date

26 January 2005

1 reference

22 December 2017

published in

Psychopharmacology

1 reference

22 December 2017

volume

180

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

73-83

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-004-2130-1

exact match

0 references

cites work

Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-004-2130-1

The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-004-2130-1

The physiological role of 5-HT2A receptors in working memory

21 January 2018

1 reference

12 December 2020

Evaluation of a rapid technique for detecting minor tranquilizers

1 reference

12 December 2020

Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2.

1 reference

12 December 2020

Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety.

1 reference

12 December 2020

New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder

1 reference

12 December 2020

Cholinergic receptor interactions and their effects on long-term memory processing.

1 reference

12 December 2020

Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review

1 reference

12 December 2020

"One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

1 reference

12 December 2020

Anxiety in the elevated zero-maze is augmented in mice after repeated daily exposure

1 reference

12 December 2020

5-HT1A receptors modulate the consolidation of learning in normal and cognitively impaired rats.

1 reference

12 December 2020

Blockade of striatal 5-HT2 receptors produces retrograde amnesia in rats

1 reference

12 December 2020

A new method for rapid screening of minor tranquillizers in mice.

1 reference

12 December 2020

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

1 reference

12 December 2020

Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.

1 reference

12 December 2020

Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats.

1 reference

12 December 2020

GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background

1 reference

12 December 2020

Factors controlling measures of anxiety and responses to novelty in the mouse

1 reference

12 December 2020

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

12 December 2020

Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice

1 reference

12 December 2020

Influence of prior experience on mice behavior using the four-plate test.

1 reference

12 December 2020

Strain-dependent involvement of D1 and D2 dopamine receptors in muscarinic cholinergic influences on memory storage.

1 reference

12 December 2020

Do animal models of anxiety predict anxiolytic-like effects of antidepressants?

1 reference

12 December 2020

Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade

1 reference

12 December 2020

Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells

1 reference

12 December 2020

One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.

1 reference

12 December 2020

The future of antidepressants

1 reference

12 December 2020

Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice

1 reference

12 December 2020

Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience

1 reference

12 December 2020

In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

1 reference

12 December 2020

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

1 reference

12 December 2020

Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms.

1 reference

12 December 2020

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

1 reference

12 December 2020

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

12 December 2020

Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine.

1 reference

12 December 2020

Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine

1 reference

12 December 2020

5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex.

1 reference

12 December 2020

Enhancement of nociceptive reactions by naloxone in mice and rats (author's transl)

1 reference

12 December 2020

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

12 December 2020

Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models

1 reference

12 December 2020

Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience

1 reference

12 December 2020

Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor

1 reference

12 December 2020

Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze.

1 reference

12 December 2020

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

12 December 2020

GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs

1 reference

12 December 2020

Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test

1 reference

12 December 2020

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

1 reference

12 December 2020

Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?

1 reference

12 December 2020

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

1 reference

12 December 2020

Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze.

1 reference

12 December 2020

A note on a simple apparatus for detecting neurological deficit in rats and mice

1 reference

12 December 2020

The interplay of learning and anxiety in the elevated plus-maze

1 reference

12 December 2020

Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior

1 reference

12 December 2020

One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze.

1 reference

12 December 2020

Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.

1 reference

12 December 2020

Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice.

1 reference

12 December 2020

Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze

1 reference

12 December 2020

10.1007/S00213-004-2130-1

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15918077

1 reference

22 December 2017